# Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and Tolerability

> **NCT01895946** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 33 (actual)

## Conditions studied

- Advanced Solid Malignancy,
- Safety and Tolerability,
- Pharmacokinetics, Pharmacodynamics,
- Tumour Response,

## Interventions

- **DRUG:** AZD5363
- **DRUG:** AZD5363

## Key facts

- **NCT ID:** NCT01895946
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2015-02
- **Final completion:** 2015-07
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2016-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01895946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01895946, "Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and Tolerability". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01895946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*